RGI
MXCT icon

River Global Investors’s MaxCyte MXCT Stock Holding History

River Global Investors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$13.5M Buy
3,253,192
+1,190,630
+58% +$4.5M 2.62% 12
2024
Q3 		$8.03M Buy
2,062,562
+93,340
+5% +$393K 1.73% 12
2024
Q2 		$7.78M Buy
1,969,222
+80,580
+4% +$347K 2.14% 10
2024
Q1 		$7.97M Buy
1,888,642
+369,996
+24% +$1.74M 2% 8
2023
Q4 		$7.05M Buy
1,518,646
+45,392
+3% +$177K 1.34% 15
2023
Q3 		$4.59M Sell
1,473,254
-69,489
-5% -$279K 1.07% 17
2023
Q2 		$7.03M Sell
1,542,743
-165,605
-10% -$761K 1.39% 14
2023
Q1 		$8.4M Buy
1,708,348
+60,110
+4% +$296K 1.72% 12
2022
Q4 		$8.75M Sell
1,648,238
-218,875
-12% -$1.34M 1.88% 8
2022
Q3 		$11.9M Sell
1,867,113
-391,387
-17% -$2.18M 2.28% 6
2022
Q2 		$10.4M Buy
2,258,500
+158,500
+8% +$781K 1.85% 8
2022
Q1 		$14.8M Sell
2,100,000
-315,500
-13% -$2.15M 1.95% 7
2021
Q4 		$24.7M Buy
2,415,500
+110,000
+5% +$1.18M 1.93% 7
2021
Q3 		$28M Buy
+2,305,500
New +$34.8M 2.17% 7

Other funds holding MXCT

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

River Global Investors's MXCT Position: Q4 2024 in Review

River Global Investors increased its MaxCyte (MXCT) stake by 58% in Q4 2024, buying an estimated $4.5M and bringing the position to 3,253,192 shares worth $13.5M. The position accounts for 2.62% of the portfolio, ranked #12.

River Global Investors first reported a position in MXCT in Q3 2021 and has held it in 14 quarters since. The position peaked at $28M in Q3 2021. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.

  • River Global Investors held 3,253,192 shares of MaxCyte worth $13.5M as of Q4 2024.
  • River Global Investors bought 1,190,630 MaxCyte shares in Q4 2024, an estimated $4.5M.
  • MaxCyte made up 2.62% of River Global Investors's portfolio in Q4 2024, its #12 holding.
  • River Global Investors first reported a position in MaxCyte in Q3 2021 and has held it in 14 quarters since.
  • River Global Investors's MaxCyte position peaked at $28M in Q3 2021.
  • 119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.

Based on River Global Investors's 13F filing for Q4 2024, filed 7 Feb 2025.